Concepedia

Josep Garcia

JG

20

Publications

1.4K

Citations

16

H-Index

2007

Active since

Affiliations

Roche (Switzerland)(Current)

Heidelberg University

Royal Marsden NHS Foundation Trust

Aix-Marseille Université

Saitama Medical University

Josep Garcia is an author at Roche (Switzerland) specializing in oncology, medicine, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2007–2022

20

Publications

20

Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial

Christopher J. Sweeney, Sergio Bracarda, Cora N. Sternberg et al. · The Lancet · 2021 · 313 citations · Full text

, , +6

Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial

Thomas Sandmann, Richard Bourgon, Josep Garcia et al. · Journal of Clinical Oncology · 2015 · 291 citations · Full text

Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial

Alan Mackay, Anna Burford, Valeria Molinari et al. · Cancer Cell · 2018 · 207 citations · Full text

Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma

Jacques Grill, Maura Massimino, Éric Bouffet et al. · Journal of Clinical Oncology · 2018 · 134 citations · Full text

Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma

Benjamin M. Ellingson, Lauren E. Abrey, Sarah J. Nelson et al. · Neuro-Oncology · 2018 · 92 citations · Full text

Rows per page

1–5 of 20